Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Long-Term Responders after Brentuximab Vedotin: Experience on 57 Patients with Relapsed and Refractory Hodgkin and Anaplastic Large Cell Lymphoma

Pier Luigi Zinzani, MD PhD, Letizia Gandolfi, Beatrice Casadei, Cinzia Pellegrini, Alessandro Broccoli, MD, Enrico Derenzini, MD, Federica Quirini, Lorenzo Tonialini, Michele Cavo, MD, Lisa Argnani, Vittorio Stefoni

Blood (2015) 126 (23): 2725.

https://doi.org/10.1182/blood.V126.23.2725.2725

Published: 2015

Journal Articles

18F-Fluorothymidine Positron Emission Tomography in Patients with Suspect Lymphoma Relapse

Alessandro Broccoli, MD, Lucia Zanoni, Cristina Nanni, Giancarlo Montini, Vittorio Stefoni, Cinzia Pellegrini, Letizia Gandolfi, Cristina Fonti, Filippo Lodi, Michele Cavo, MD, Stefano Fanti, Pier Luigi Zinzani, MD PhD

Blood (2015) 126 (23): 5009.

https://doi.org/10.1182/blood.V126.23.5009.5009

Published: 2015

Journal Articles

Phase II Study of the Fondazione Italiana Linfomi on Gemcitabine Plus Romidepsin (GEMRO Regimen) in Relapsed and Refractory Peripheral T-Cell Lymphoma Patients

Blood (2015) 126 (23): 3937.

https://doi.org/10.1182/blood.V126.23.3937.3937

Published: 2015

Journal Articles

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice, the Lenamant Study

Blood (2015) 126 (23): 3946.

https://doi.org/10.1182/blood.V126.23.3946.3946

Published: 2015

Journal Articles

The Treatment of Primary Mediastinal Large B-Cell Lymphoma: A Two Decades Monocentric Experience on 98 Patients

Beatrice Casadei, MD, Alessandro Broccoli, MD, Vittorio Stefoni, MD, Cinzia Pellegrini, Letizia Gandolfi, MD, Enrico Derenzini, MD, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 4440.

https://doi.org/10.1182/blood.V124.21.4440.4440

Published: 2014

Journal Articles

Efficacy and Safety of Biosimilar Epoetin Alpha in Patients with Chronic Lymphoproliferative Syndromes and Chemotherapy-Induced Anemia: An Observational, Retrospective, Monocentric Analysis

Alessandro Broccoli, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Letizia Gandolfi, MD, Cinzia Pellegrini, Federica Quirini, MD, Vittorio Stefoni, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 5478.

https://doi.org/10.1182/blood.V124.21.5478.5478

Published: 2014

Journal Articles

Langerhans Cell Histiocytosis: A Single Institution Retrospective Analysis of Eleven Patients

Vittorio Stefoni, MD, Alessandro Broccoli, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Letizia Gandolfi, MD, Cinzia Pellegrini, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 5458.

https://doi.org/10.1182/blood.V124.21.5458.5458

Published: 2014

Journal Articles

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Enrico Derenzini, MD, Vittorio Stefoni, MD, Beatrice Casadei, MD, Cinzia Pellegrini, MD, Alessandro Broccoli, MD, Stefano Fanti, MD, Letizia Gandolfi, MD, Giulia Stefani, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD

Blood (2013) 122 (21): 5543.

https://doi.org/10.1182/blood.V122.21.5543.5543

Published: 2013

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Pier Luigi Zinzani, Cinzia Pellegrini, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Federica Quirini, MD, Lisa Argnani, PhD, Vittorio Stefoni, MD

Blood (2013) 122 (21): 3046.

https://doi.org/10.1182/blood.V122.21.3046.3046

Published: 2013

Journal Articles

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

Pier Luigi Zinzani, MD, Cinzia Pellegrini, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Vittorio Stefoni, MD, Beatrice Casadei, MD, Federica Quirini, MD, Lisa Argnani, PhD

Blood (2012) 120 (21): 2736.

https://doi.org/10.1182/blood.V120.21.2736.2736

Published: 2012

Journal Articles

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Cinzia Pellegrini, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Vittorio Stefoni, MD, Letizia Gandolfi, MD, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 2721.

https://doi.org/10.1182/blood.V120.21.2721.2721

Published: 2012

Journal Articles

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

Enrico Derenzini, MD, Cinzia Pellegrini, MD, Roberto Maglie, Vittorio Stefoni, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Beatrice Casadei, MD, Federica Quirini, MD, Lisa Argnani, PhD, Stefano Fanti, MD, Maria Rosa Motta, PhD, Michele Baccarani, MD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 3019.

https://doi.org/10.1182/blood.V120.21.3019.3019

Published: 2012

Journal Articles

Fludarabine and Mitoxantrone Followed by Yttrium-90 Ibritumumab Tiuxetan in Untreated Patients with Follicular Lymphoma. Long Term Efficacy and Toxicity Results of the FLUMIZ Trial.

Pier Luigi Zinzani, MD, PhD, Enrico Derenzini, MD, Cinzia Pellegrini, Luigi Rigacci, Alberto Fabbri, Federica Quirini, Vittorio Stefoni, Letizia Gandolfi, Lisa Argnani, Beatrice Casadei, Alessandro Broccoli, Alessandro Pulsoni, MD, Marco Gobbi, MD, Alessio Perrotti, Alfonso Zaccaria, Maria Teresa Voso, MD, Maria Giuseppina Cabras, Amalia De Renzo, Michele Baccarani, MD

Blood (2011) 118 (21): 1604.

https://doi.org/10.1182/blood.V118.21.1604.1604

Published: 2011

Journal Articles

Early Interim 18 f-FDG PET In Hodgkin's Lymphoma: Evaluation on 304 Patients

Blood (2010) 116 (21): 3879.

https://doi.org/10.1182/blood.V116.21.3879.3879

Published: 2010

Journal Articles

Predictive role of Early Interim FDG-PET in Hodgkin Lymphoma.

Vittorio Stefoni, Alessandro Broccoli, Lapo Alinari, Valentina Ambrosini, Enrico Derenzini, Stefano Fanti, Mariapaola Fina, Letizia Gandolfi, Enrica Marchi, Cinzia Pellegrini, Federica Quirini, Pier Luigi Zinzani, Michele Baccarani

Blood (2009) 114 (22): 1659.

https://doi.org/10.1182/blood.V114.22.1659.1659

Published: 2009

Journal Articles

A Phase II Trial of R-FM (Rituximab, Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Untreated Follicular Lymphoma (FL) Patients.

Pier Luigi Zinzani, Monica Tani, Alessandro Broccoli, Enrico Derenzini, Alessandro Pulsoni, Amalia De Renzo, Stefano Fanti, Mariapaola Fina, Letizia Gandolfi, Cinzia Pellegrini, Vittorio Stefoni, Michele Baccarani

Blood (2009) 114 (22): 3743.

https://doi.org/10.1182/blood.V114.22.3743.3743

Published: 2009

Journal Articles

A Phase II Trial of Rituximab-CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Pier Luigi Zinzani, Mariapaola Fina, Monica Tani, Vittorio Stefoni, Letizia Gandolfi, Alessandro Broccoli, Cinzia Pellegrini, Enrico Derenzini, Giuseppe Rossi, MD, Emanuele Angelucci, Gianluca Gaidano, Maria Concetta Petti, Maurizio Martelli, Umberto Vitolo, Stefano Fanti, Michele Baccarani

Blood (2009) 114 (22): 2720.

https://doi.org/10.1182/blood.V114.22.2720.2720

Published: 2009

NARROW

Long-Term Responders after Brentuximab Vedotin: Experience on 57 Patients with Relapsed and Refractory Hodgkin and Anaplastic Large Cell Lymphoma

18F-Fluorothymidine Positron Emission Tomography in Patients with Suspect Lymphoma Relapse

Phase II Study of the Fondazione Italiana Linfomi on Gemcitabine Plus Romidepsin (GEMRO Regimen) in Relapsed and Refractory Peripheral T-Cell Lymphoma Patients

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice, the Lenamant Study

The Treatment of Primary Mediastinal Large B-Cell Lymphoma: A Two Decades Monocentric Experience on 98 Patients

Efficacy and Safety of Biosimilar Epoetin Alpha in Patients with Chronic Lymphoproliferative Syndromes and Chemotherapy-Induced Anemia: An Observational, Retrospective, Monocentric Analysis

Langerhans Cell Histiocytosis: A Single Institution Retrospective Analysis of Eleven Patients

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

Fludarabine and Mitoxantrone Followed by Yttrium-90 Ibritumumab Tiuxetan in Untreated Patients with Follicular Lymphoma. Long Term Efficacy and Toxicity Results of the FLUMIZ Trial.

Early Interim 18 f-FDG PET In Hodgkin's Lymphoma: Evaluation on 304 Patients

Predictive role of Early Interim FDG-PET in Hodgkin Lymphoma.

A Phase II Trial of R-FM (Rituximab, Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Untreated Follicular Lymphoma (FL) Patients.

A Phase II Trial of Rituximab-CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only